Utility of cytology microarray constructed from effusion cell blocks for immunomarker validation.
Pu RT, Giordano TJ, Michael CW
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of staining a CMA versus a cell block on IHC analysis of effusions from lung, ovary, breast and gastrointestinal tumors. Fresh cells were collected, fixed in formalin, and embedded in paraffin. Three 0.6 mm cores were selected by H&E staining from each block.
Summary of Findings
When the original cytology block had less than 10% tumor cells, some of the CMA cores lacked tumor cells, but of these cases, at least one of three cores contained tumor cells. When section 45 of the CMA was compared to the original block and the first CMA section, 19 of 23 cases still had 3 cores present, but 1 case had no cores left. 21 of 23 cases stained positive for AE1/AE3, but the other two cases had insufficient tumor cells to be included. Among the specimens included, EMA and AE1/AE3 staining was completely concordant regarding stain intensity between the original block and the cores. Ki-67 staining was similar between the CMA and the original block for 16 specimens, but 3 cases were discordant and 4 cases were excluded due to insufficient tumor cells in the CMA. In breast cancer cases, staining of CK7, CK20, ER and PR was completely concordant between CMA and the original blocks for all 5 specimens. Similarly, complete concordance was established for CK7, CK20 and TTF-1 between the CMA and original blocks of the 5 lung cancer specimens. The 8 ovarian cancer specimens showed complete concordance between staining of the CMA and the original blocks for WT-1. Although CK20 staining was completely concordant between the gastrointestinal tract CMA and cell blocks, 1 case was negative for CK7 on the CMA and positive in the original cell block.
Biospecimens
CellLungCellOvaryCellBreastCellColorectalCellEsophagusCellSmall BowelCellStomachPreservation Types
FormalinDiagnoses
NeoplasticNeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryProteinCytology microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location BreastGastrointestinal tractLungOvaryBiospecimen Aliquots and Components Aliquot sequential collection 1st section45th sectionBiospecimen Aliquots and Components Type of slide Cell block sectionCytology microarrayImmunohistochemistry Specific Targeted peptide/protein AE1/AE3CK20CK7EMAERKi-67PRTTF-1WT-1